BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24382352)

  • 21. Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-β signaling.
    Feng Y; Wu H; Xu Y; Zhang Z; Liu T; Lin X; Feng XH
    J Biol Chem; 2014 Jan; 289(4):2072-83. PubMed ID: 24324267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
    Chen HB; Rud JG; Lin K; Xu L
    J Biol Chem; 2005 Jun; 280(22):21329-36. PubMed ID: 15799969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
    Seo T; Park J; Choe J
    Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    Poncelet AC; Schnaper HW
    J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
    Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
    EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in protein-binding hot-spots on the hub protein Smad3 differentially affect its protein interactions and Smad3-regulated gene expression.
    Schiro MM; Stauber SE; Peterson TL; Krueger C; Darnell SJ; Satyshur KA; Drinkwater NR; Newton MA; Hoffmann FM
    PLoS One; 2011; 6(9):e25021. PubMed ID: 21949838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
    Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
    Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
    J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.
    Zhao S; Ammanamanchi S; Brattain M; Cao L; Thangasamy A; Wang J; Freeman JW
    J Biol Chem; 2008 Apr; 283(17):11293-301. PubMed ID: 18310076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
    Zhang Y; Feng XH; Derynck R
    Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
    De Bosscher K; Hill CS; Nicolás FJ
    Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation.
    Poncelet AC; Schnaper HW; Tan R; Liu Y; Runyan CE
    J Biol Chem; 2007 May; 282(21):15534-40. PubMed ID: 17400544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
    Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
    J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.
    Mori Y; Chen SJ; Varga J
    Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS.
    Sun Y; Ding L; Zhang H; Han J; Yang X; Yan J; Zhu Y; Li J; Song H; Ye Q
    Nucleic Acids Res; 2006; 34(21):6314-26. PubMed ID: 17099224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
    Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
    Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.